Eli Lilly and Company News Headlines

LLY 
$72
*  
0.11
0.15%
Get LLY Alerts
*Delayed - data as of Jan. 30, 2015  -  Find a broker to begin trading LLY now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Bright Prospects at Bayer - Analyst Blog
1/3/2014 11:10:01 AM - Zacks.com


Dogging The Markets: End-Of-Year Update
1/2/2014 2:22:00 AM - Seeking Alpha


U.S. Approval for NVO's Tretten - Analyst Blog
12/27/2013 11:02:10 AM - Zacks.com


Diabetes Programs Now Crucial For Eli Lilly
12/23/2013 8:15:00 AM - Seeking Alpha


ImmunoGen Amends Lilly Agreement - Analyst Blog
12/16/2013 5:33:21 PM - Zacks.com


Guru Stocks at 52-Week Lows: IBM, T, TLK, LLY, GLD
12/16/2013 10:49:04 AM - GuruFocus


Evaluating Lilly's Dividend Prospects In Light Of Cymbalta Patent Expiration
12/14/2013 1:06:00 AM - Seeking Alpha


Eli Lilly & Company (LLY): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
12/13/2013 7:00:01 AM - Zacks.com


3 Healthcare Sector Dogs Seek 15% To 50% November Upsides
12/12/2013 4:59:00 PM - Seeking Alpha


Sanofi's Update on Lyxumia - Analyst Blog
12/10/2013 2:23:26 PM - Zacks.com


Another R&D Failure for Eli Lilly - Analyst Blog
12/6/2013 11:05:29 AM - Zacks.com


OncoMed Progresses with Oncology Candidate - Analyst Blog
12/5/2013 5:50:01 PM - Zacks.com


Positive Phase III Data on Sanofi's U300 - Analyst Blog
12/4/2013 5:05:24 PM - Zacks.com


Health Care Heartiest, Gold Funds All Red In November
12/3/2013 6:41:00 PM - Investor's Business Daily


Pharma & Biotech Stock Outlook - Dec 2013 - Zacks Analyst Interviews
12/3/2013 4:28:01 AM - Zacks.com


Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook
12/3/2013 4:28:01 AM - Zacks.com


Positive CHMP Opinion Sends Celgene Soaring - Analyst Blog
11/25/2013 11:30:01 AM - Zacks.com


Recent Cloud IPO Veeva Systems Scores In Health Biz
11/22/2013 4:31:00 PM - Investor's Business Daily


QIAGEN, Eli Lilly Expand Partnership - Analyst Blog
11/19/2013 6:58:01 PM - Zacks.com


ImmunoGen Rises on Licensing Deal - Analyst Blog
11/12/2013 5:05:50 PM - Zacks.com


Stock Upgrades: SeaWorld Set to Make a Splash
11/12/2013 8:19:00 AM - Minyanville


Lower-than-Expected Loss at OncoGenex - Analyst Blog
11/8/2013 3:05:28 PM - Zacks.com


What Ranbaxy's Fraud Says About the State of Big Pharma Research
11/8/2013 10:07:00 AM - Minyanville


Prolific Selling - Hussman's High-Impact Moves Mirror Insiders
11/5/2013 10:51:01 AM - GuruFocus


We Like What We're Seeing In Big Pharma
11/5/2013 4:15:00 AM - Seeking Alpha